Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, and Department of Pediatrics, Zhongxiao Branch, Taipei City Hospital, Taipei, Taiwan.
J Agric Food Chem. 2010 Jan 13;58(1):108-11. doi: 10.1021/jf902872j.
High-performance liquid chromatography with tandem mass spectrometry (HPLC/MS/MS) was used to determine melamine oral bioavailability (BA) and urinary excretion. Organ distribution after a 14-day consecutive oral melamine administration (100 mg/kg/day, once a day) was also evaluated. A noncompartmental model was utilized to obtain pharmacokinetic parameters. According to the results, the BA of melamine was estimated to be 98.1%. Approximately 63% of administered melamine was recovered in urine within 96 h after a single oral administration (100 mg/kg). The bladder had the highest melamine concentration of all the organs after a 14-day consecutive oral administration of melamine, and almost no melamine was found in the rat brain. This result indicated that the oral absorption of melamine was almost complete and urinary excretion was the major route for its elimination. Repeated exposure to high-dose melamine may result in only slight accumulation in organs.
高效液相色谱-串联质谱法(HPLC/MS/MS)用于测定三聚氰胺的口服生物利用度(BA)和尿排泄。还评估了连续 14 天口服三聚氰胺(100mg/kg/天,每天一次)后的器官分布。利用非房室模型获得药代动力学参数。结果表明,三聚氰胺的 BA 估计为 98.1%。单次口服(100mg/kg)后 96 小时内,约有 63%的给予的三聚氰胺在尿液中回收。连续 14 天口服三聚氰胺后,膀胱中三聚氰胺的浓度最高,而在大鼠脑中几乎没有发现三聚氰胺。这一结果表明,三聚氰胺的口服吸收几乎是完全的,尿液排泄是其消除的主要途径。重复暴露于高剂量三聚氰胺可能只会导致器官内的轻微蓄积。